Targeting amino acid metabolism for cancer therapy

Area of Science:

• Oncology
• Cancer Metabolism
• Biochemistry

Background:

• Tumor cells exhibit metabolic reprogramming to support biomass accumulation.
• Oncogenic signals regulate nutrient transporters and metabolic enzymes, driving cell-cycle progression.
• Antimetabolites were early cancer therapies targeting tumor metabolism, with renewed interest in metabolic drug development.

Purpose of the Study:

• To explore the concept of 'metabolic addictions' in cancer.
• To review strategies for exploiting cancer cell dependencies on amino acids.
• To highlight the importance of model systems and patient stratification for clinical translation.

Main Methods:

• Review of existing literature on cancer metabolism and therapeutic strategies.
• Analysis of oncogenic signaling pathways affecting nutrient transporters and metabolic enzymes.
• Discussion of approaches targeting amino acid supply, uptake, and synthesis/catabolism.

Main Results:

• Many cancers display heightened demand for specific amino acids, relying on external sources or increased internal production.
• Targeting these amino acid dependencies can involve serum depletion, transporter inhibition, or enzyme blockade.
• The effectiveness of therapies is influenced by the choice of model systems and the identification of specific patient populations.

Conclusions:

• Exploiting cancer's metabolic dependencies, particularly on amino acids, is a viable therapeutic strategy.
• Successful clinical advancement requires careful selection of model systems and targeted patient groups.
• Targeting tumor metabolism represents a significant area for developing novel cancer treatments.